56 related articles for article (PubMed ID: 22614984)
1. Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study.
Kang S; Nam BH; Park JY; Seo SS; Ryu SY; Kim JW; Kim SC; Park SY; Nam JH
J Clin Oncol; 2012 Jul; 30(19):2369-74. PubMed ID: 22614984
[TBL] [Abstract][Full Text] [Related]
2. Evolving standards and future directions for systemic therapies in cervical cancer.
Ang DJM; Chan JJ
J Gynecol Oncol; 2024 Mar; 35(2):e65. PubMed ID: 38282261
[TBL] [Abstract][Full Text] [Related]
3. Prognostic models for locally advanced cervical cancer: external validation of the published models.
Lora D; Gómez de la Cámara A; Fernández SP; Enríquez de Salamanca R; Gómez JFPR
J Gynecol Oncol; 2017 Sep; 28(5):e58. PubMed ID: 28657220
[TBL] [Abstract][Full Text] [Related]
4. East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
Enomoto T; Okamoto A; Kim JH; Lai CH; Wu X; Kim YM
J Gynecol Oncol; 2023 Sep; 34(5):e86. PubMed ID: 37593814
[TBL] [Abstract][Full Text] [Related]
5. Controversies in the Staging of Patients with Locally Advanced Cervical Cancer.
Nasioudis D; George EM; Tanyi JL
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238231
[TBL] [Abstract][Full Text] [Related]
6. Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study.
Yan WT; Li C; Yao LQ; Qiu HB; Wang MD; Xu XF; Zhou YH; Wang H; Chen TH; Gu WM; Zhong JH; Wu H; Pawlik TM; Lau WY; Shen F; Yang T
Hepatobiliary Surg Nutr; 2023 Apr; 12(2):155-168. PubMed ID: 37124678
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients.
Thephamongkhol K; Korpraphong P; Muangsomboon K; Sitathanee C; Lertkhachonsuk AA; Phongkitkarun S; Srirattanapong S; Prapruttam D; Bridhikitti J; Dendumrongsup T; Alisanant P; Amornwichet N; Khorprasert C; Sasiwimonphan K; Tanprasertkul C; Dhanachai M; Patumanond J; Setakornnukul J
Sci Rep; 2022 Jun; 12(1):9873. PubMed ID: 35701437
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Short-Term Imaging and Squamous Cell Carcinoma Antigen to Early Predict Response to Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
Yoo JG; Kim SI; Yeo SG; Park DC
Cancer Control; 2022; 29():10732748221074530. PubMed ID: 35196888
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
Harima Y; Ariga T; Kaneyasu Y; Ikushima H; Tokumaru S; Shimamoto S; Takahashi T; Ii N; Tsujino K; Saito AI; Ushijima H; Toita T; Ohno T
PLoS One; 2021; 16(11):e0259235. PubMed ID: 34727105
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy.
Zhang G; Miao L; Wu H; Zhang Y; Fu C
Technol Cancer Res Treat; 2021; 20():15330338211044626. PubMed ID: 34605696
[No Abstract] [Full Text] [Related]
11. A study on the clinical value of
Qi C; He S; Cai L; Zhang L; Ding H; Chen Y
Oncol Lett; 2021 Nov; 22(5):746. PubMed ID: 34539850
[TBL] [Abstract][Full Text] [Related]
12. Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal.
He B; Chen W; Liu L; Hou Z; Zhu H; Cheng H; Zhang Y; Zhan S; Wang S
Front Public Health; 2021; 9():654454. PubMed ID: 34026714
[No Abstract] [Full Text] [Related]
13. Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?
Yuan Z; Cao D; Zhang Y; Shen K; Yang J; Yu M; Zhou H
Risk Manag Healthc Policy; 2021; 14():109-116. PubMed ID: 33469394
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Extended-Field Irradiation in Patients With Cervical Cancer: A Literature Review.
Wang W; Zhou Y; Wang D; Hu K; Zhang F
Front Oncol; 2020; 10():579410. PubMed ID: 33123482
[TBL] [Abstract][Full Text] [Related]
15. A preoperative radiomics model for the identification of lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Yan L; Yao H; Long R; Wu L; Xia H; Li J; Liu Z; Liang C
Br J Radiol; 2020 Dec; 93(1116):20200358. PubMed ID: 32960673
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with Para-Aortic Lymph Node Failure after pelvic irradiation in patients with Cervical Cancer.
Wang W; Wang D; Liu X; Zhou Y; Ma J; Hou X; Hu K; Zhang F
J Cancer; 2020; 11(17):5099-5105. PubMed ID: 32742457
[No Abstract] [Full Text] [Related]
17. Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: a retrospective observational study.
He X; Liu J; Xiao L; Zhao M; Su T; Liu T; Han G; Wang Y
BMC Cancer; 2020 May; 20(1):381. PubMed ID: 32370739
[TBL] [Abstract][Full Text] [Related]
18. Prognosis-Predicting Model Based on [
Lee WK; Chong GO; Jeong SY; Lee HJ; Park SH; Ryu JM; Choi YS; Kang S; Koo YJ; Lee DH; Kong E; Lee SW
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32033340
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status.
Jeong SY; Park H; Kim MS; Kang JH; Paik ES; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
Cancer Res Treat; 2020 Apr; 52(2):516-523. PubMed ID: 31671937
[TBL] [Abstract][Full Text] [Related]
20. The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.
Fu J; Wang W; Wang Y; Liu C; Wang P
Radiat Oncol; 2019 Aug; 14(1):146. PubMed ID: 31416463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
